Mohammad Nouri Selected Research

Hyperandrogenism

6/2020	Nicotinamide and its metabolite N1-Methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome.
1/2015	Evaluation of relationship between serum levels of anti-müllerian hormone, androgen, and insulin resistant with retrieval oocytes in overweight patients with polycystic ovary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Nouri Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 01/2012
13	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2022 - 01/2015
11	Inflammation (Inflammations) 01/2023 - 01/2012
9	Breast Neoplasms (Breast Cancer) 01/2023 - 04/2015
9	Infertility (Sterility) 10/2022 - 02/2014
8	Neoplasm Metastasis (Metastasis) 03/2021 - 12/2017
6	Insulin Resistance 10/2021 - 01/2015
5	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2014
5	Hypoxia (Hypoxemia) 10/2021 - 10/2018
5	Coronary Artery Disease (Coronary Atherosclerosis) 09/2021 - 01/2017
5	Endometriosis 01/2021 - 01/2012
5	Atherosclerosis 01/2019 - 07/2015
4	Wounds and Injuries (Trauma) 12/2022 - 09/2010
4	Primary Ovarian Insufficiency 01/2022 - 06/2018
4	Necrosis 01/2022 - 11/2016
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2019
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 12/2016
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 11/2016
3	Multiple Sclerosis 01/2023 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 06/2022 - 01/2020
3	Azoospermia 01/2022 - 06/2021
3	Female Infertility 01/2022 - 07/2018
3	Heart Diseases (Heart Disease) 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 12/2021 - 06/2018
2	Acidosis 01/2023 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2020
2	Anemia 01/2022 - 01/2019
2	Sepsis (Septicemia) 01/2022 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2019
2	Infections 11/2020 - 11/2017
2	Sudden Infant Death (SID) 09/2020 - 01/2020
2	Hyperandrogenism 06/2020 - 01/2015
2	Melanoma (Melanoma, Malignant) 05/2020 - 01/2013
2	Diarrhea 01/2020 - 05/2006
2	Behcet Syndrome (Behcet's Syndrome) 12/2019 - 01/2019
2	Spontaneous Abortion (Miscarriage) 11/2019 - 09/2017
2	Stomach Neoplasms (Stomach Cancer) 10/2019 - 01/2014
2	Infarction (Infarctions) 07/2019 - 01/2019
2	Myocardial Infarction 07/2019 - 12/2018
2	Habitual Abortion (Recurrent Miscarriage) 01/2019 - 12/2017
2	Reperfusion Injury 01/2019 - 12/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2018
2	Relapsing-Remitting Multiple Sclerosis 08/2018 - 01/2018
2	Diabetes Mellitus 11/2017 - 09/2010
2	Overweight 07/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2015
10	MelatoninIBA 02/2024 - 11/2016
10	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2014
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2010
8	Hormones (Hormone)IBA 02/2022 - 01/2015
7	Therapeutic UsesIBA 02/2024 - 12/2017
6	CytokinesIBA 01/2019 - 01/2013
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 11/2016
5	LipidsIBA 10/2021 - 12/2016
5	Vitamin D FDA LinkGeneric 09/2020 - 06/2015
4	AntioxidantsIBA 01/2023 - 09/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 09/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2015
4	SteroidsIBA 01/2021 - 08/2018
4	AntigensIBA 01/2020 - 01/2013
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 01/2012
3	apatinibIBA 03/2022 - 01/2020
3	NF-kappa B (NF-kB)IBA 01/2022 - 10/2018
3	Estradiol (Delestrogen)FDA LinkGeneric 10/2021 - 06/2015
3	Testosterone (Sustanon)FDA Link 10/2021 - 07/2017
3	Follicle Stimulating Hormone (Follitropin)FDA Link 10/2021 - 06/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 09/2017
3	SolutionsIBA 05/2020 - 05/2006
3	AntibodiesIBA 01/2020 - 03/2017
3	Single-Chain AntibodiesIBA 01/2020 - 01/2012
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 01/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 06/2022
2	tyrosine receptor (receptor, tyrosine)IBA 01/2024 - 11/2017
2	Phosphotransferases (Kinase)IBA 01/2024 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 05/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2013
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2021
2	dapagliflozinIBA 01/2022 - 01/2022
2	Chemokine CX3CL1IBA 01/2022 - 05/2020
2	Busulfan (Busulfex)FDA Link 01/2022 - 06/2021
2	SodiumIBA 01/2022 - 01/2020
2	thymoquinoneIBA 10/2021 - 03/2021
2	PolyphenolsIBA 10/2021 - 06/2021
2	SirtuinsIBA 10/2021 - 12/2018
2	Anti-Mullerian HormoneIBA 06/2021 - 01/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2021 - 03/2021
2	CollagenIBA 01/2021 - 07/2019
2	Cadherins (E-Cadherin)IBA 01/2021 - 08/2020
2	N(1)-methylnicotinamideIBA 06/2020 - 10/2019
2	ElectrolytesIBA 01/2020 - 05/2006
2	Immunoglobulin FragmentsIBA 01/2020 - 10/2019
2	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2019 - 07/2017
2	HDL LipoproteinsIBA 01/2019 - 01/2017
2	GonadotropinsIBA 07/2018 - 06/2018
2	CholesterolIBA 01/2017 - 01/2017

Therapy/Procedure

24	Therapeutics 02/2024 - 06/2018
9	Drug Therapy (Chemotherapy) 02/2024 - 01/2020
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2019
2	Rejuvenation 01/2022 - 12/2021